Investor repositioning drives shift in Asia quant markets, BofA Securities conference shows
Key points BofA Securities hosted its second annual Asia Pacific Integrated Quant Services Senior Leadership Conference i…
Press Releases by PR Newswire
Hankook's Ventus Delivers Unwavering Performance Throughout WRC FORUM8 Rally Japan's Ever-Changing Conditions
Round 7 of the 2026 WRC unfolded across the Aichi and Gifu regions of Japan, featuring fierce competition on rugged mount…
Calibrite Display Plus HL Receives Apple Approval for Hardware-Level Display Calibration
For the first time, creative professionals can calibrate Apple displays at hardware level — with a colorimeter priced for…
BofA Securities Asia Forum Gathers Global Investors Amid Surge in Hedge Funds Allocations
Key points BofA Securities hosted its fourth annual Asia Alternatives Forum, bringing together more than 20 hedge fund ma…
Traveloka 6.6 Mid Year Sale: Up to S$66 Off Flights, Hotels and Attractions for Singapore Travelers
Traveloka’s 6.6 Mid Year Sale Unlocks $66 Sitewide Discounts and 1-for-1 Attraction Deals SINGAPORE, June 1, 2026 /…
Deloitte appoints Robert Hillard as Asia Pacific Chief Executive Officer
HONG KONG, June 1, 2026 /PRNewswire/ — Deloitte Asia Pacific today announced the appointment of Robert Hillard as A…
UOB and FPT sign MoU to advance AI, technology transformation and financial innovation opportunities
SINGAPORE, June 1, 2026 /PRNewswire/ — UOB and global technology corporation FPT have signed a Memorandum of U…
Long-term Follow-up Results of CARsgen's Satri-cel as Sequential Therapy After First-Line Treatment for Gastric Cancer Presented at the 2026 ASCO Annual Meeting
SHANGHAI, June 1, 2026 /PRNewswire/ — CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focuse…
ASCO 2026 | CStone Presents Updated Clinical Data for CS2009 (PD-1/VEGF/CTLA-4 Trispecific Antibody), Reinforcing Triple-Target Synergy and Delivering Strong Proof-of-Concept
First-line NSCLC – Compelling Activity Across All PD-L1 SubgroupsIn first-line non-small cell lung cancer (NSCLC) patient…
MICROIP to Debut "AI Vehicle System Business Group" and Edge AI Innovations at COMPUTEX 2026
TAIPEI, June 1, 2026 /PRNewswire/ — MICROIP (TPEx: 7796), specializing in AI software and ASIC design services…
Jyong Biotech CEO Outlines FDA Pathway and Global Strategy in PharmaBoardroom Live Interview
TAIPEI, June 1, 2026 /PRNewswire/ — Jyong Biotech Ltd. (Nasdaq: MENS) (the "Company" or "Jyong Biote…
D3 Bio Presents First-Line Data for Elisrasib (D3S-001) at ASCO 2026; Next-Generation KRAS G12C Inhibitor Shows Landmark Efficacy in Untreated NSCLC
Elisrasib monotherapy delivers an ORR of 78.0% and median PFS of 12.4 months in first-line KRAS G12C–mutant NSCLC (n=41) …
ImmVira Reports 100% Complete Response Rate at 9 Months in Bladder Carcinoma in Situ with MVR-T3011 at ASCO
SUZHOU, China, June 1, 2026 /PRNewswire/ — ImmVira Group ("ImmVira") today announced that preliminary Pha…
2026 ASCO | Innovent Presents Preliminary PoC Data of IBI363 (TAK-928) PD-1/IL-2α-bias bispecific fusion protein) in First-line Advanced NSCLC
IBI363 in combination with chemotherapy demonstrated encouraging efficacy signals and manageable safety in the first-line…
2026 ASCO | Innovent Presents Long-Term Follow-up Results from the PoC Study of IBI363 (TAK-928) (PD-1/IL-2α-bias bispecific fusion protein), Showing Robust Survival Benefits in Advanced Immunotherapy-Resistant Non-Small Cell Lung Cancer
After long-term follow-up, IBI363 monotherapy demonstrated strong overall survival (OS) with a long tail effect in IO-res…
New Taipei City Showcases Smart Manufacturing Strength at AUTOMATE 2026
Exploring New Business Opportunities with Global Buyers TAIPEI, June 1, 2026 /PRNewswire/ — The New Taipei City Gov…
